Clinical Trials Directory

Trials / Completed

CompletedNCT00196183

Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation

Randomized Study Comparing Pulmonary Vein Isolation Alone vs. Pulmonary Vein Isolation Plus Electrogram-Guided Substrate Ablation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Deutsches Herzzentrum Muenchen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare two strategies of catheter-based treatment of paroxysmal atrial fibrillation: Pulmonary vein isolation either alone or combined with electrogram-guided substrate-ablation.

Detailed description

Catheter ablation has evolved an accepted alternative in the curative treatment of atrial fibrillation (AF). However, discussion about the best ablation strategy is still ongoing. In patients with paroxysmal AF, it has been reproducibly demonstrated that curing rates of approximately 65-70% can be achieved with the electric isolation of pulmonary veins (PV) eliminating the initiating triggers of AF episodes. Recently, a new catheter ablation approach targeting in both atria fractionated, complex electrograms during ongoing AF and modifying thus the substrate maintaining AF has been described. The first describer of this technique reports curing rates of 92%. We want to compare in a randomized prospective study the treatment by PV isolation alone with a combined approach of PV isolation together with ablation of fractionated complex electrograms in patients with paroxysmal AF. Study endpoint is the achievement of stable sinus rhythm as assessed by 7 days holter ECG in the absence of antiarrhythmic drug treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREtrigger-guided catheter-ablationtrigger-guided ablation of paroxysmal atrial fibrillation
PROCEDUREtrigger+substrate-guided catheter ablationtrigger-+substrate guided ablation of paroxysmal atrial fibrillation

Timeline

Start date
2004-08-01
Completion
2006-06-01
First posted
2005-09-20
Last updated
2008-03-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00196183. Inclusion in this directory is not an endorsement.